IRWD
Ironwood Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$645.28M
P/E Ratio
6.32
EPS
$0.62
Beta
0.30
52W High
$5.78
52W Low
$0.56
50-Day MA
$3.79
200-Day MA
$3.05
Dividend Yield
—
Profit Margin
28.30%
Forward P/E
12.33
PEG Ratio
-0.26
About Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $361.51M |
| Gross Profit (TTM) | $271.87M |
| EBITDA | $203.88M |
| Operating Margin | 68.10% |
| Return on Equity | -575.00% |
| Return on Assets | 33.20% |
| Revenue/Share (TTM) | $2.23 |
| Book Value | $-1.32 |
| Price-to-Book | 2.59 |
| Price-to-Sales (TTM) | 1.78 |
| EV/Revenue | 2.828 |
| EV/EBITDA | 4.93 |
| Quarterly Earnings Growth (YoY) | 1047.00% |
| Quarterly Revenue Growth (YoY) | 158.90% |
| Shares Outstanding | $164.61M |
| Float | $136.34M |
| % Insiders | 2.93% |
| % Institutions | 98.30% |
Historical Volatility
HV 10-Day
73.91%
HV 20-Day
83.19%
HV 30-Day
87.21%
HV 60-Day
82.67%
HV Rank
17.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.10 target)
1
Strong Buy1
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026